Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380448082> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W4380448082 abstract "Abstract Background and Aims The recurrence of IgA nephropathy (rIgAN) worsens the prognosis of renal transplantation, representing the third cause of loss in these recipients. Several variables at the time of recurrence, such as worse renal function, greater proteinuria, previous steroid withdrawal, and MEST-C histological findings have been associated with a higher risk of graft loss after recurrence. The presence of clinical or subclinical inflammation has been associated with a higher risk of kidney graft loss, but it is not precisely known how it influences the outcome of patients with rIgAN. Method A multicenter retrospective study was carried out including renal transplant recipients with biopsy-proven IgA nephropathy as the underlying disease in which the recurrence of the primary disease had been verified by means of graft biopsy and in which the Banff criteria were available or could be reviewed. Cellular inflammation was defined according to Banff scores as “t” or “i” ≥2. The main endpoint was progression to CKD stage 5 or death censored-graft loss (DCGL). Results 118 kidney transplant recipients were included with an age of 47 ± 14 years at recurrence, 80% male, with a mean time to biopsy of 65 ± 69 months and a post-transplant follow-up of 118 ± 70 months. After recurrence, 34 (28.8%) transplants were lost after 35 ± 28 months, excluding death. Using univariate Cox regression, the factors related to CKD stage 5 or graft loss were systolic blood pressure (HR 1.039, 95%CI 1.016-1.064, p = 0.001), glomerular filtration rate (HR 0.948, 95%CI 0.922-0.974, p <0.001), the logarithm of proteinuria (HR 15.836, 95% CI 5.504-45.565, p < 0.001), Oxford-C score (HR 3.490, 95% CI 2.137-5.699, p <0.001), interstitial fibrosis (HR 2.173, 95% CI 1.362-3.468, p = 0.001) and cellular inflammation (HR 2.458, 95% CI 1.237-4.884, p = 0.010). After multivariate analysis, cellular inflammation remained significantly related to CKD stage 5 or DCGL (HR 2.338, 95% CI 1.077-5.075, p = 0.032). independently of systolic blood pressure, glomerular filtration rate, the logarithm of proteinuria and Oxford-C score. Conclusion In addition to the previously described factors usually related to worse evolution of IgA nephropathy in the native kidney and after post-transplant recurrence, we observed that cellular inflammation influences worse evolution after rIgAN. We suggest to considering the Banff criteria for acute cellular inflammation to better understand the subsequent evolution of patients with rIgAN." @default.
- W4380448082 created "2023-06-14" @default.
- W4380448082 creator A5008178442 @default.
- W4380448082 creator A5015361378 @default.
- W4380448082 creator A5015559162 @default.
- W4380448082 creator A5036020725 @default.
- W4380448082 creator A5041708444 @default.
- W4380448082 creator A5041733116 @default.
- W4380448082 creator A5045854773 @default.
- W4380448082 creator A5059815722 @default.
- W4380448082 creator A5066491567 @default.
- W4380448082 creator A5079438766 @default.
- W4380448082 date "2023-06-01" @default.
- W4380448082 modified "2023-10-17" @default.
- W4380448082 title "#5393 INFLUENCE OF CELLULAR INFLAMMATION ON THE OUTCOME OF KIDNEY TRANSPLANTATION AFTER RECURRENCE OF IGA NEPHROPATHY" @default.
- W4380448082 doi "https://doi.org/10.1093/ndt/gfad063a_5393" @default.
- W4380448082 hasPublicationYear "2023" @default.
- W4380448082 type Work @default.
- W4380448082 citedByCount "0" @default.
- W4380448082 crossrefType "journal-article" @default.
- W4380448082 hasAuthorship W4380448082A5008178442 @default.
- W4380448082 hasAuthorship W4380448082A5015361378 @default.
- W4380448082 hasAuthorship W4380448082A5015559162 @default.
- W4380448082 hasAuthorship W4380448082A5036020725 @default.
- W4380448082 hasAuthorship W4380448082A5041708444 @default.
- W4380448082 hasAuthorship W4380448082A5041733116 @default.
- W4380448082 hasAuthorship W4380448082A5045854773 @default.
- W4380448082 hasAuthorship W4380448082A5059815722 @default.
- W4380448082 hasAuthorship W4380448082A5066491567 @default.
- W4380448082 hasAuthorship W4380448082A5079438766 @default.
- W4380448082 hasBestOaLocation W43804480821 @default.
- W4380448082 hasConcept C113280763 @default.
- W4380448082 hasConcept C126322002 @default.
- W4380448082 hasConcept C126894567 @default.
- W4380448082 hasConcept C134018914 @default.
- W4380448082 hasConcept C141071460 @default.
- W4380448082 hasConcept C144301174 @default.
- W4380448082 hasConcept C159641895 @default.
- W4380448082 hasConcept C2775934546 @default.
- W4380448082 hasConcept C2778653478 @default.
- W4380448082 hasConcept C2779561371 @default.
- W4380448082 hasConcept C2780091579 @default.
- W4380448082 hasConcept C2780303639 @default.
- W4380448082 hasConcept C2781184683 @default.
- W4380448082 hasConcept C2911091166 @default.
- W4380448082 hasConcept C38180746 @default.
- W4380448082 hasConcept C555293320 @default.
- W4380448082 hasConcept C71924100 @default.
- W4380448082 hasConcept C90924648 @default.
- W4380448082 hasConceptScore W4380448082C113280763 @default.
- W4380448082 hasConceptScore W4380448082C126322002 @default.
- W4380448082 hasConceptScore W4380448082C126894567 @default.
- W4380448082 hasConceptScore W4380448082C134018914 @default.
- W4380448082 hasConceptScore W4380448082C141071460 @default.
- W4380448082 hasConceptScore W4380448082C144301174 @default.
- W4380448082 hasConceptScore W4380448082C159641895 @default.
- W4380448082 hasConceptScore W4380448082C2775934546 @default.
- W4380448082 hasConceptScore W4380448082C2778653478 @default.
- W4380448082 hasConceptScore W4380448082C2779561371 @default.
- W4380448082 hasConceptScore W4380448082C2780091579 @default.
- W4380448082 hasConceptScore W4380448082C2780303639 @default.
- W4380448082 hasConceptScore W4380448082C2781184683 @default.
- W4380448082 hasConceptScore W4380448082C2911091166 @default.
- W4380448082 hasConceptScore W4380448082C38180746 @default.
- W4380448082 hasConceptScore W4380448082C555293320 @default.
- W4380448082 hasConceptScore W4380448082C71924100 @default.
- W4380448082 hasConceptScore W4380448082C90924648 @default.
- W4380448082 hasIssue "Supplement_1" @default.
- W4380448082 hasLocation W43804480821 @default.
- W4380448082 hasOpenAccess W4380448082 @default.
- W4380448082 hasPrimaryLocation W43804480821 @default.
- W4380448082 hasRelatedWork W1486584413 @default.
- W4380448082 hasRelatedWork W2055890431 @default.
- W4380448082 hasRelatedWork W2057091235 @default.
- W4380448082 hasRelatedWork W2079077757 @default.
- W4380448082 hasRelatedWork W2087086071 @default.
- W4380448082 hasRelatedWork W2101150587 @default.
- W4380448082 hasRelatedWork W2117838252 @default.
- W4380448082 hasRelatedWork W2771864650 @default.
- W4380448082 hasRelatedWork W2917493079 @default.
- W4380448082 hasRelatedWork W3028727574 @default.
- W4380448082 hasVolume "38" @default.
- W4380448082 isParatext "false" @default.
- W4380448082 isRetracted "false" @default.
- W4380448082 workType "article" @default.